Kirsten Moffatt
Director of Business Development at Smithers Avanza- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
LinkedIn User
Kirsten is very detail-oriented and knows how to get th job done. She is very responsive to questions and concerns and was always on time. You always know that you can count on her and I have recommended her to work as a consultant based on her performance in this position.
LinkedIn User
Kirsten is very detail-oriented and knows how to get th job done. She is very responsive to questions and concerns and was always on time. You always know that you can count on her and I have recommended her to work as a consultant based on her performance in this position.
LinkedIn User
Kirsten is very detail-oriented and knows how to get th job done. She is very responsive to questions and concerns and was always on time. You always know that you can count on her and I have recommended her to work as a consultant based on her performance in this position.
LinkedIn User
Kirsten is very detail-oriented and knows how to get th job done. She is very responsive to questions and concerns and was always on time. You always know that you can count on her and I have recommended her to work as a consultant based on her performance in this position.
Experience
-
-
Director of Business Development
-
Apr 2015 - Present
Smithers Avanza Bioanalytical Services is a high quality GLP, GCP and CLIA-certified CRO that partners with pharma and biotech companies for the development of biotherapeutics. We specialize in the development and validation of TK/PK, ADA, cell-based, and protein biomarker assays to support sample analysis from all phases of development. Platforms currently include Singulex, MSD, and ELISA, and we will be adding the GyroLab in fall of 2016. Smithers Avanza Bioanalytical Services is a high quality GLP, GCP and CLIA-certified CRO that partners with pharma and biotech companies for the development of biotherapeutics. We specialize in the development and validation of TK/PK, ADA, cell-based, and protein biomarker assays to support sample analysis from all phases of development. Platforms currently include Singulex, MSD, and ELISA, and we will be adding the GyroLab in fall of 2016.
-
-
-
Epistem Ltd.
-
United Kingdom
-
Biotechnology Research
-
1 - 100 Employee
-
Sr. Business Development Manager, Contract Research Services
-
Nov 2013 - Mar 2015
Epistem is a biotechnology company commercializing its expertise in stem cells in the areas of epithelial (oncology, gastrointestinal and dermatological) and infectious diseases. Epistem develops innovative therapeutics, biomarkers and diagnostics (Genedrive®) alongside contract research services to drug development companies. The Group’s core expertise is focused around the regulation of adult stem cells located in epithelial tissue including the gastrointestinal tract, skin, hair follicles, breast and prostate and utilizing novel and proprietary next generation molecular biology. Epistem operates three distinct divisions, Contract Research Services, Novel Therapies and Personalised Medicine (Biomarkers and Diagnostics).
-
-
-
-
Business Development Manager
-
Oct 2011 - Dec 2012
Sold LC/MS-based bioanalytical testing to pharmaceutical and biotechnology companies located in the eastern half of the US and Canada. Protea’s service offering includes: advanced proteomics, early to late discovery, mass spectrometry imaging, and regulated bioanalysis of small and large molecules for PK and biomarker analysis (method development, validation, and sample analysis) in support of all phases of drug development. Sold LC/MS-based bioanalytical testing to pharmaceutical and biotechnology companies located in the eastern half of the US and Canada. Protea’s service offering includes: advanced proteomics, early to late discovery, mass spectrometry imaging, and regulated bioanalysis of small and large molecules for PK and biomarker analysis (method development, validation, and sample analysis) in support of all phases of drug development.
-
-
-
-
Sales Manager
-
Oct 2008 - Oct 2011
Responsible for selling core bioanalytical testing services for both small molecule drugs (LC/MS/MS) and biologics (immunochemistry) in support of discovery and regulated preclinical and Phase I-IV clinical trials. Additional services included: LC/MS macromolecule assays (PK and biomarker), sample management (kits and sample storage), biomarkers (LC/MS and immunoassay) and P450 inhibition assays. Responsible for selling core bioanalytical testing services for both small molecule drugs (LC/MS/MS) and biologics (immunochemistry) in support of discovery and regulated preclinical and Phase I-IV clinical trials. Additional services included: LC/MS macromolecule assays (PK and biomarker), sample management (kits and sample storage), biomarkers (LC/MS and immunoassay) and P450 inhibition assays.
-
-
-
NA
-
Australia
-
Travel Arrangements
-
Independant Consultant
-
Jul 2008 - Oct 2008
Independant consultant in process management for a range of companies within the preclinical industry, as well as to biotech/pharma market specialists. Independant consultant in process management for a range of companies within the preclinical industry, as well as to biotech/pharma market specialists.
-
-
-
LabCorp
-
United States
-
Hospitals and Health Care
-
700 & Above Employee
-
Director of Business Development-Esoterix
-
Mar 2005 - Feb 2008
-
-
-
Gene Logic
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Director of Toxiocology
-
2002 - 2005
-
-
Education
-
1995 - 2000
University of Colorado Anschutz Medical Campus
PhD, Experimental Pathology
Community
